Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

Int J Clin Oncol. 2017 Aug;22(4):805-806. doi: 10.1007/s10147-017-1146-6.
No abstract available

Publication types

  • Published Erratum